An Official Website of the United States Government
Company Information:
Name:
Altea Therapeutics Corporation
Address:
Altea Therapeutics Corporation
2056 Weems Road
Tucker, GA 30084
2056 Weems Road
Tucker, GA 30084
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
(678) 495-3108
Award Totals:
Award List:
N/A
Award Year / Program / Phase:
2000 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Harry K. Delcher
Award Amount:
$99,442.00
N/A
Award Year / Program / Phase:
2000 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Harry K. Delcher
Award Amount:
$97,910.00
NEEDLE FREE INSULIN INFUSION WITH THERMAL MICROPORATION
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Harry K. Delcher
Award Amount:
$0.00
Abstract:
The goal of this proposal over Phase I and II SBIR studies and subsequent full scale development is to commercialize a noninvasive insulin infusion system that is painless, convenient, discrete, safe, efficacious and cost-effective. Such a system will bridge the gap between the tight glucose control… More
NEEDLE FREE INSULIN INFUSION WITH THERMAL MICROPORATION
Award Year / Program / Phase:
2002 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Harry K. Delcher
Award Amount:
$391,878.00
Abstract:
The goal of this proposal over Phase I and II SBIR studies and subsequent full scale development is to commercialize a noninvasive insulin infusion system that is painless, convenient, discrete, safe, efficacious and cost-effective. Such a system will bridge the gap between the tight glucose control… More
RAPID TRANSDERMAL DELIVERY OF OPIOID PAIN MEDICATIONS
Award Year / Program / Phase:
2002 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Alan M. Smith
Award Amount:
$105,650.00
Abstract:
DESCRIPTION (provided by applicant): The American Medical Association reports that undertreatment of pain is a major problem for cancer patients as well as for other disease conditions. Approximately 50-75% of cancer patients have pain that is undertreated, and 25% die in severe unrelieved pain.… More
Transdermal Hydromorphone for Acute and Chronic Pain
Award Year / Program / Phase:
2005 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Alan M. Smith
Award Amount:
$781,633.00
Abstract:
DESCRIPTION (provided by applicant): Founded in 1998, Altea Therapeutics is developing its PassPort(tm) system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This breakthrough technology, currently… More
Non-Invasive Drug Delivery by Thermal Microporation
Award Year / Program / Phase:
2005 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Michael Hatch
Award Amount:
$100,660.00
Abstract:
DESCRIPTION (provided by applicant):
Founded in 1998, Altea Therapeutics is developing its PassPort(tm) transdermal drug delivery system to deliver proteins and peptides, small-molecule drugs, genes and vaccines from a skin patch, eliminating the need for invasive needle injection. This… More